Join us on October 24 for an exclusive webinar introducing the newest member of the Simple Western family – the Leo™ System! Discover how this new system can transform western blots into quantitative bioanalytical methods suitable for adoption for robust quantitative measures of protein expression ranging from gene therapy potency to TPD studies. 🧪🔬 👉 Don’t miss this opportunity to learn how Simple Western is paving the way for faster and more reliable protein research. Register now: https://bit.ly/3ZGfTkS #SimpleWestern #Bio-techne #genetherapy #TPD #Webinar
Bio-Techne
Biotechnology Research
Minneapolis, Minnesota 50,296 followers
Empowering scientists & clinicians by providing high-quality reagents, analytical instruments, & precision diagnostics.
About us
Bio-Techne is headquartered in Minneapolis, Minnesota and employs over 3,000 people globally at 34 locations worldwide. As a global developer, manufacturer and supplier of high-quality reagents, analytical instruments and precision diagnostics, Bio-Techne has an extensive catalog of over 500,000 products. Incorporated in 1981 as R&D Systems, the company changed its name to Bio-Techne in 2014. Our growth has been accelerated through acquisitions, organic investments, diversification of our customer base and expansion into new markets. In fiscal year 2023, Bio-Techne delivered net sales of over $1.1 billion. Bio-Techne includes the following brands: ACD, Asuragen, ExosomeDx, Lunaphore, Novus Biologicals, ProteinSimple, R&D Systems and Tocris Bioscience.
- Website
-
http://www.bio-techne.com/
External link for Bio-Techne
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Minneapolis, Minnesota
- Type
- Public Company
Locations
-
Primary
614 McKinley Place NE
Minneapolis, Minnesota 55413, US
Employees at Bio-Techne
-
Brett Houser
-
Geoffrey Grove (林杰富)
Senior Product Manager
-
Andrew Stobbe
Senior IT Manager & DevOps SRE Leader | Driving Innovation in Web Ops & Platform Development
-
Kurt Donner
Business Leader - Spatial Genomics & Multiomics - Gene Therapy - Cell Therapy - RNAi/ASO - Biomarkers - Single-cell Biology - Life Sciences - Biotech…
Updates
-
Amy Ripka, founder and CEO of Lucy Therapeutics joined us on Back of the Napkin podcast. Click below to hear how relentless curiosity led her and her team to pivotal breakthroughs in developing therapeutics for Parkinson's and Rett syndrome. Listen now: https://spoti.fi/4ef2uEy or https://apple.co/4eg6zII
-
Listen to Back of the Napkin and hear Founder and Director of the Centre for Targeted Protein Degradation, Alessio Ciulli, recount the stories behind his key contributions to the field of targeted protein degradation. Listen now: https://spoti.fi/4d9jjj2 or https://apple.co/3BlrOKp
-
Be inspired by Episode 1 of Back of the Napkin. Matt Disney, Professor at the University of Florida Scripps Institute, is comfortable with being uncomfortable. His pioneering work has led to the explosion of a new field in drug discovery: targeting RNA with small molecules. 🎙️#Sciencepodcast #biotech #RNA #Innovation Listen now: https://apple.co/3AEPpFL or https://spoti.fi/4dLIEAQ
-
Join Scott Schachtele and Charles Haitjema for an insightful presentation at #SfN24 exploring TREM2 signaling in Alzheimer's disease models with the innovative Simple Western automated technology. 📅 Date: Monday, October 7 🕜 Time: 2:30 - 3:00 PM 📍 Location: Exhibit Hall, Aisle 900, Product Theater #1 Get the full details: https://lnkd.in/djAm-49S
-
Connect with us at your nearest iCE User Meeting! We are coming to Boston, Philadelphia, Research Triangle Park, San Diego, and San Francisco. Don’t miss out on an exciting opportunity to network with your peers, hear about the latest iCE applications, share best practices, provide feedback to development team, and discover what’s new with the Maurice and MauriceFlex Platforms. Please RSVP using this registration form to secure your seat at your preferred location. Seats are limited so don't delay! Register Now: https://bit.ly/4djXw8b
-
Explore the benefits of culturing your T cells or tumor-infiltrating lymphocytes (TILs) with our new IL-2 Heat Stable Agonist Protein. Engineered using artificial intelligence (AI), this protein has enhanced stability, enabling it to withstand high temperatures and extended culture durations. Download the Application Note: https://bit.ly/4eJwWGH
-
Back of the Napkin presents another great chapter in the story of targeted protein degradation (TPD). Join Alessio Ciulli, Founder and Director at the Centre for Targeted Protein Degradation, in his adventures in unlocking the secrets of TPD that are revolutionizing disease treatment. Listen now: https://apple.co/3BlrOKp or https://spoti.fi/4eyRBNw
-
A library of 240 compounds for GPCR research. Combining pharmacological and chemical diversity, it is designed for HTS, HCS, target validation and assay development. Learn More - https://bit.ly/3TFoQXJ #drugdiscovery, #drugdevelopment, #screening, #compoundlibraries
-
Achieve greater assay sensitivity! In this application note, explore how utilizing high sensitivity mode on the INTELLIFLEX® instrument combined with R&D Systems™ Luminex® assays, can expand analyte detection and ensure more precise and reliable data, enabling improved experimental design and decision making— particularly for multifaceted studies like signaling pathway analysis and multi-parameter immune profiling. https://bit.ly/3Ba7Hit #Luminex #BioTechne #Multiplexing